During the pandemic, the FDA eased limitations on telehealth prescriptions and mail delivery for certain drugs — including abortion pills, which can be used safely and effectively in the first 10 weeks of pregnancy. In December, the FDA made that access permanent — but so far, telehealth startups aren’t jumping to provide the pills. Companies including Hims & Hers, Nurx, Tia, and PillPack, many of which frame their offerings around reduced stigma and increased sexual freedom, have chosen not to offer the treatment, with some employees citing fear that political controversy could harm their businesses’ growth. STAT’s Olivia Goldhill has the full story.

READ MORE FROM THE ORIGINAL SOURCE HERE